Sodium-Glucose Cotransporter-2 Inhibitors (SGLT-2i) Reduce Hospitalization for Heart Failure Only and Have No Effect on Atherosclerotic Cardiovascular Events: A Meta-Analysis

INTRODUCTION: Although the positive effects of sodium-glucose cotransporter-2 inhibitors (SGLT-2i) on hospitalization for heart failure in type 2 diabetes (T2D) seem definite, some doubt exists about their effects on atherosclerotic cardiovascular disease (ASCVD). This study aims to shed light on th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinha, Binayak, Ghosal, Samit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531596/
https://www.ncbi.nlm.nih.gov/pubmed/30875065
http://dx.doi.org/10.1007/s13300-019-0597-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531596/
https://www.ncbi.nlm.nih.gov/pubmed/30875065
http://dx.doi.org/10.1007/s13300-019-0597-3

Ejemplares similares